MDXG
MiMedx Group IncNASDAQ
Healthcare • Biotechnology
Factor tilt: Small-Cap Blend
$3.31+0.91%
Close Nov 6, 2026
- Market cap
- $493.01M
- 1 month
- -28.4%
- 3 months
- -22.5%
- 1 year
- -58.4%
- 52-week range
- $3.09$7.71
- Dividend
- No dividends on record
- Short interest
- 8.1% of float9.3M shares · settled Oct 15, 2026 · -1.1% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $303.73M
- Net income
- -$19.19M
- Free cash flow
- $20.36M
- Book value
- $211.08M
- Total debt
- —
- P/E
- —
- Price / sales
- 1.6×
- Price / book
- 2.3×
- FCF yield
- +4.1%
- Net margin
- -6.3%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors.
Read more
Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.
- Website
- mimedx.com
- Headquarters
- Marietta, GA, United States
- Employees
- 808
- Listed
- Aug 22, 2007
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 30, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Oct 28, 2026 | $62.3M | -45.2% | 79.8% | -$11.7M | -$8.7M |
| Jun 2026filed Jul 29, 2026 | $64.4M | -34.7% | 69.0% | -$18.5M | -$14.8M |
| Mar 2026filed Apr 29, 2026 | $59.0M | -33.1% | 70.6% | -$16.0M | -$10.9M |
| Dec 2025filed Feb 25, 2026 | $118.1M | +27.1% | 83.9% | $21.1M | $15.2M |
| Sep 2025filed Oct 29, 2025 | $113.7M | +35.3% | 83.5% | $22.2M | $16.7M |
| Jun 2025filed Jul 30, 2025 | $98.6M | +13.1% | 81.1% | $12.4M | $9.6M |
| Mar 2025filed Apr 30, 2025 | $88.2M | +4.1% | 81.2% | $8.3M | $7.0M |
| Dec 2024filed Feb 26, 2025 | $92.9M | +7.0% | 81.8% | $11.1M | $7.4M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 25, 2026 | $418.6M | +20.0% | 82.6% | $63.9M | $48.6M |
| Dec 2024filed Feb 26, 2025 | $348.9M | +8.5% | 82.8% | $58.9M | $42.4M |
| Dec 2023filed Feb 28, 2024 | $321.5M | +20.0% | 83.0% | $37.1M | $67.4M |
| Dec 2022filed May 1, 2023 | $267.8M | +10.7% | 82.0% | -$14.7M | -$30.2M |
| Dec 2021filed Feb 28, 2022 | $242.0M | -2.5% | 83.6% | -$7.1M | -$12.3M |
| Dec 2020filed Mar 8, 2021 | $248.2M | -30.9% | 84.2% | -$45.4M | -$49.3M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched MDXG. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
9,264,529 shares short
-98,370 shares (-1.1%) vs Sep 30, 2026
8.1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
9,362,899 shares short
-1,397,804 shares (-13%) vs Sep 15, 2026
8.2% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
10,760,703 shares short
+1,375,762 shares (+14.7%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
9,384,941 shares short
+493,771 shares (+5.6%) vs Aug 14, 2026
8% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
8,891,170 shares short
+456,178 shares (+5.4%) vs Jul 31, 2026
7.5% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
8,434,992 shares short
+913,426 shares (+12.1%) vs Jul 15, 2026
7.1% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind MDXG’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
647 for 2000 · reverse split
Effective Apr 2, 2008
Each 2000 pre-split shares become 647 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if MDXG is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: LOW
28 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 27, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
228 filers reported a long position in MDXG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
67.4%
of the 111.9M shares 13-F filers reported
Moves vs Q1 2026
8 added1 trimmed
1 unchanged
Net shares held
+8.8%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Essex Woodlands Management, Inc. | $108.6M · 28.2M shares | 28.2M | Unchanged |
| 2 | BlackRock, Inc. | $46.8M · 12.2M shares | 12.2M | +2% |
| 3 | Trigran Investments, Inc. | $27.6M · 7.2M shares | 7.2M | 0% |
| 4 | STATE STREET CORP | $21.5M · 5.6M shares | 5.6M | +10.3% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $20M · 5.2M shares | 5.2M | +0.4% |
| 6 | Nantahala Capital Management, LLC | $18.4M · 4.8M shares | 4.8M | +40.3% |
| 7 | PARADIGM CAPITAL MANAGEMENT INC/NY | $15.7M · 4.1M shares | 4.1M | +19.4% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $12.1M · 3.1M shares | 3.1M | +9.1% |
| 9 | GOLDMAN SACHS GROUP INC | $10.3M · 2.7M shares | 2.7M | +124.8% |
| 10 | AQR CAPITAL MANAGEMENT LLC | $9.5M · 2.5M shares | 2.5M | +170.3% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inGet the Full Analysis for MDXG
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.